UIM5:F:F-UBS (Lux) Fund Solutions - MSCI Japan UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 50.69

Change

0.00 (0.00)%

Market Cap

USD 109.59B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.24 (+0.88%)

USD 139.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

-0.28 (-0.05%)

USD 96.22B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.44 (+0.79%)

USD 91.00B
SXRZ:F iShares VII PLC - iShares Nikk..

+1.85 (+0.78%)

USD 54.70B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.12 (+0.81%)

USD 52.21B
VUAA:F Vanguard S&P 500 UCITS Acc

N/A

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.45 (+0.46%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.01 (-0.10%)

USD 40.38B
0ZC:F Zscaler Inc

+1.24 (+0.81%)

USD 37.92B
BSND:F Danone SA

+0.10 (+0.80%)

USD 33.83B

ETFs Containing UIM5:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.86% 60% D- 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.86% 57% F 56% F
Trailing 12 Months  
Capital Gain 12.37% 55% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.37% 51% F 53% F
Trailing 5 Years  
Capital Gain 23.10% 48% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.10% 48% F 44% F
Average Annual (5 Year Horizon)  
Capital Gain 5.85% 59% D- 60% D-
Dividend Return 5.85% 57% F 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.72% 59% D- 84% B
Risk Adjusted Return 49.92% 60% D- 69% C-
Market Capitalization 109.59B 100% F 98% N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike